Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.93 USD | -9.47% |
|
-8.99% | +83.43% |
Financials (USD)
Sales 2024 * | 71.9M | Sales 2025 * | 66.95M | Capitalization | 1.22B |
---|---|---|---|---|---|
Net income 2024 * | -172M | Net income 2025 * | -213M | EV / Sales 2024 * | 12.8 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 297M | EV / Sales 2025 * | 13.8 x |
P/E ratio 2024 * |
-6.78
x | P/E ratio 2025 * |
-6.21
x | Employees | 284 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.82% |
Latest transcript on Nurix Therapeutics, Inc.
1 day | -9.47% | ||
1 week | -8.99% | ||
Current month | -9.30% | ||
1 month | +20.19% | ||
3 months | +27.39% | ||
6 months | +85.23% | ||
Current year | +83.43% |
![Extreme 18.865](/images/extremecours_fleche.png)
![Extreme 14.44](/images/extremecours_fleche.png)
![Extreme 7.65](/images/extremecours_fleche.png)
![Extreme 4.22](/images/extremecours_fleche.png)
![Extreme 4.22](/images/extremecours_fleche.png)
![Extreme 4.22](/images/extremecours_fleche.png)
![Extreme 4.22](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 58 | 14-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Judith Reinsdorf
BRD | Director/Board Member | 60 | 21-09-30 |
Paul Silva
BRD | Director/Board Member | 58 | 21-09-30 |
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 18.93 | -9.47% | 868,306 |
24-07-01 | 20.91 | +0.19% | 983,151 |
24-06-28 | 20.87 | +0.63% | 3,926,432 |
24-06-27 | 20.74 | +1.37% | 528,514 |
24-06-26 | 20.46 | -1.63% | 1,198,652 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.43% | 1.22B | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.57% | 26.22B | |
-25.37% | 19.01B | |
-19.77% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- NRIX Stock